3,820
Views
48
CrossRef citations to date
0
Altmetric
Research Articles

Targeting SARS-COV-2 non-structural protein 16: a virtual drug repurposing study

, , , , &
Pages 4633-4646 | Received 18 May 2020, Accepted 02 Jun 2020, Published online: 23 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Jobin Thomas, Sanjit Kumar & Jitendra Satija. (2023) Integrated molecular and quantum mechanical approach to identify novel potent natural bioactive compound against 2′-O-methyltransferase (nsp16) of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-14.
Read now
Mukesh Kumar, Anik Roy, Ravindra Singh Rawat, Amit Alok, Kishore K. R. Tetala, Nihar Ranjan Biswas, Punit Kaur & Sanjit Kumar. (2022) Identification and structural studies of natural inhibitors against SARS-CoV-2 viral RNA methyltransferase (NSP16). Journal of Biomolecular Structure and Dynamics 40:24, pages 13965-13975.
Read now
Vinicius S. Nunes, Diego F. S. Paschoal, Luiz Antônio S. Costa & Hélio F. Dos Santos. (2022) Antivirals virtual screening to SARS-CoV-2 non-structural proteins. Journal of Biomolecular Structure and Dynamics 40:19, pages 8989-9003.
Read now
Akbar Noorbakhsh, Elnaz Hosseininezhadian Koushki, Chiako Farshadfar & Noeman Ardalan. (2022) Designing a natural inhibitor against human kynurenine aminotransferase type II and a comparison with PF-04859989: a computational effort against schizophrenia. Journal of Biomolecular Structure and Dynamics 40:15, pages 7038-7051.
Read now
Bilal J. M. Aldahham, Khattab Al-Khafaji, Mohanad Yakdhan Saleh, Adel Mohamed Abdelhakem, Amer M. Alanazi & Md Ataul Islam. (2022) Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study. Journal of Biomolecular Structure and Dynamics 40:9, pages 3899-3906.
Read now
Yuanyuan Jiang, Lanxin Liu, Morenci Manning, Madison Bonahoom, Aaron Lotvola, Zhe Yang & Zeng-Quan Yang. (2022) Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus. Journal of Biomolecular Structure and Dynamics 40:3, pages 1331-1346.
Read now
Shubhangi Kandwal & Darren Fayne. (2022) Repurposing drugs for treatment of SARS-CoV-2 infection: computational design insights into mechanisms of action. Journal of Biomolecular Structure and Dynamics 40:3, pages 1316-1330.
Read now

Articles from other publishers (41)

Donald Tam, Ana C. Lorenzo-Leal, Luis Ricardo Hernández & Horacio Bach. (2023) Targeting SARS-CoV-2 Non-Structural Proteins. International Journal of Molecular Sciences 24:16, pages 13002.
Crossref
Sareh Kakavandi, Iman Zare, Maryam VaezJalali, Masoud Dadashi, Maryam Azarian, Abdullatif Akbari, Marzieh Ramezani Farani, Hamidreza Zalpoor & Bahareh Hajikhani. (2023) Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases. Cell Communication and Signaling 21:1.
Crossref
Rahul Singh & Rituraj Purohit. (2023) Multi‐target approach against SARS‐CoV ‐2 by stone apple molecules: A master key to drug design . Phytotherapy Research.
Crossref
Subodh Kumar, Harvinder Singh, Manisha Prajapat, Phulen Sarma, Anusuya Bhattacharyya, Hardeep Kaur, Gurjeet Kaur, Nishant Shekhar, Karanveer Kaushal, Kalpna Kumari, Seema Bansal, Saniya Mahendiratta, Arushi Chauhan, Ashutosh Singh, Rahul Soloman Singh, Saurabh Sharma, Prasad Thota, Pramod Avti, Ajay Prakash, Anurag Kuhad & Bikash Medhi. (2023) Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation. Bioinformatics and Biology Insights 17.
Crossref
Nahid Shahabadi, Saba Zendehcheshm, Mohammad Mahdavi & Fatemeh Khademi. (2023) Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective. Informatics in Medicine Unlocked 36, pages 101147.
Crossref
Jiapu ZhangJiapu Zhang. 2023. Optimization-based Molecular Dynamics Studies of SARS-CoV-2 Molecular Structures. Optimization-based Molecular Dynamics Studies of SARS-CoV-2 Molecular Structures 645 710 .
Wenjing Gu, Hui Gan, Yu Ma, Lina Xu, Zhangkai J. Cheng, Bizhou Li, Xinxing Zhang, Wujun Jiang, Jinlv Sun, Baoqing Sun & Chuangli Hao. (2022) The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity. Virology Journal 19:1.
Crossref
Shivangi Agrawal, Ekta Pathak, Rajeev Mishra, Vibha Mishra, Afifa Parveen, Sunil Kumar Mishra, Parameswarappa S. Byadgi, Sushil Kumar Dubey, Ashvanee Kumar Chaudhary, Vishwambhar Singh, Rameshwar Nath Chaurasia & Neelam Atri. (2022) Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host. Computers in Biology and Medicine 149, pages 106049.
Crossref
Zheng Yao Low, Nur Zawanah Zabidi, Ashley Jia Wen Yip, Ashwini Puniyamurti, Vincent T. K. Chow & Sunil K. Lal. (2022) SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion. Viruses 14:9, pages 1991.
Crossref
Fang-Shu Shi, Yin Yu, Ya-Li Li, Lilan Cui, Zhuangzhuang Zhao, Mi Wang, Bin Wang, Rong Zhang & Yao-Wei Huang. (2022) Expression Profile and Localization of SARS-CoV-2 Nonstructural Replicase Proteins in Infected Cells. Microbiology Spectrum 10:4.
Crossref
Lama Abdurrahman, Xiaoqian Fang & Yonghong Zhang. (2022) Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments. Current Molecular Medicine 22:7, pages 621-639.
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Arifa Sultana, Md. Jamal Hossain, Md. Ruhul Kuddus, Mohammad A. Rashid, Miss Sharmin Zahan, Saikat Mitra, Arpita Roy, Safaet Alam, Md. Moklesur Rahman Sarker & Isa Naina Mohamed. (2022) Ethnobotanical Uses, Phytochemistry, Toxicology, and Pharmacological Properties of Euphorbia neriifolia Linn. against Infectious Diseases: A Comprehensive Review. Molecules 27:14, pages 4374.
Crossref
Arijit Ghosh, Paritosh K. Kar, Anupam Gautam, Rahul Gupta, Rajveer Singh, Rudra Chakravarti, Velayutham Ravichandiran, Shubhra Ghosh Dastidar, Dipanjan Ghosh & Syamal Roy. (2022) An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives. RSC Medicinal Chemistry 13:6, pages 647-675.
Crossref
Felipe Torres, Miguel Kiwi & Ivan K. Schuller. (2022) The impact of the suppression of highly connected protein interactions on the corona virus infection. Scientific Reports 12:1.
Crossref
Tim R Fischer, Laurenz Meidner, Marvin Schwickert, Marlies Weber, Robert A Zimmermann, Christian Kersten, Tanja Schirmeister & Mark Helm. (2022) Chemical biology and medicinal chemistry of RNA methyltransferases. Nucleic Acids Research 50:8, pages 4216-4245.
Crossref
Alexey Sulimov, Danil Kutov, Ivan Ilin, Yibei Xiao, Sheng Jiang & Vladimir Sulimov. (2022) Novel Inhibitors of 2′-O-Methyltransferase of the SARS-CoV-2 Coronavirus. Molecules 27:9, pages 2721.
Crossref
Saurov Mahanta, Tufan Naiya, Kunal Biswas, Liza Changkakoti, Yugal Kishore Mohanta, Bhaben Tanti, Awdhesh Kumar Mishra, Tapan Kumar Mohanta & Nanaocha Sharma. (2022) Plant Source Derived Compound Exhibited In Silico Inhibition of Membrane Glycoprotein In SARS-CoV-2: Paving the Way to Discover a New Class of Compound For Treatment of COVID-19. Frontiers in Pharmacology 13.
Crossref
P. G. Pronkin & A.S. Tatikolov. (2022) Molecular Docking of Cyanine and Squarylium Dyes with NSP15 Endoribonuclease of the SARS-CoV-2 Coronavirus. Russian Journal of Physical Chemistry B 16:1, pages 1-8.
Crossref
Shaun D Black. (2022) Molecular Modeling and Preliminary Clinical Data Suggesting Antiviral Activity for Chlorpheniramine (Chlorphenamine) Against COVID-19. Cureus.
Crossref
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, Rituraj Purohit & Sanjay Kumar. (2022) In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors. Journal of Traditional and Complementary Medicine 12:1, pages 35-43.
Crossref
Alessandra Galati, Livia Scatolini, Emanuela Micheli, Francesca Bavasso, Alessandro Cicconi, Paolo Maccallini, Lu Chen, Caitlin M. Roake, Stefan Schoeftner, Steven E. Artandi, Maurizio Gatti, Stefano Cacchione & Grazia D. Raffa. (2021) The S‐adenosylmethionine analog sinefungin inhibits the trimethylguanosine synthase TGS1 to promote telomerase activity and telomere lengthening. FEBS Letters 596:1, pages 42-52.
Crossref
Pavel Pronkin & Alexander Tatikolov. (2021) Molecular docking of cyanine and squarylium dyes with SARS‐CoV‐2 proteases NSP3, NSP5 and NSP12. Quantitative Biology 9:4, pages 440-450.
Crossref
Mahdie Rahban, Agata Stanek, Amirreza Hooshmand, Yasaman Khamineh, Salma Ahi, Syed Naqui Kazim, Faizan Ahmad, Vladimir Muronetz, Mohamed Samy Abousenna, Samaneh Zolghadri & Ali A. Saboury. (2021) Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. Journal of Clinical Medicine 10:21, pages 4802.
Crossref
Ibrahim H. Eissa, Mohamed M. Khalifa, Eslam B. Elkaeed, Elsayed E. Hafez, Aisha A. Alsfouk & Ahmed M. Metwaly. (2021) In Silico Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10. Molecules 26:20, pages 6151.
Crossref
Sefer BADAY. (2021) Drug Repurposing Against SARS-CoV-2: Targeting NSP16-NSP10 Interaction. Journal of the Turkish Chemical Society Section A: Chemistry 8:3, pages 933-940.
Crossref
Aditya K. Padhi, Soumya Lipsa Rath & Timir Tripathi. (2021) Accelerating COVID-19 Research Using Molecular Dynamics Simulation. The Journal of Physical Chemistry B 125:32, pages 9078-9091.
Crossref
Majid Hassanzadeganroudsari, Amir Ahmadi, Niloufar Rashidi, Md Hossain, Amanda Habib & Vasso Apostolopoulos. (2021) Computational Chemistry to Repurposing Drugs for the Control of COVID-19. Biologics 1:2, pages 111-128.
Crossref
Julia Liang, Eleni Pitsillou, Lucy Burbury, Andrew Hung & Tom C. Karagiannis. (2021) In silico investigation of potential small molecule inhibitors of the SARS-CoV-2 nsp10-nsp16 methyltransferase complex. Chemical Physics Letters 774, pages 138618.
Crossref
Ruichao Mao, Lihua Bie, Maofeng Xu, Xiaocong Wang & Jun Gao. (2021) Antiviral drug design based on the opening mechanism of spike glycoprotein in SARS-CoV-2. Physical Chemistry Chemical Physics 23:22, pages 12549-12558.
Crossref
Zahra Hesari, Samaneh Zolghadri, Sajad Moradi, Mohsen Shahlaei & Elham Tazikeh-Lemeski. (2021) Computational Discovery of SARS-CoV-2 NSP 16 Drug Candidates Based on Pharmacophore Modeling and Molecular Dynamics Simulation. Journal of Computational Biophysics and Chemistry 20:04, pages 377-390.
Crossref
Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Khaled S. Allemailem, Ahmad Almatroudi, Mahmoud F. Moustafa & Mohamed-Elamir F. Hegazy. (2021) In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors. The Protein Journal 40:3, pages 296-309.
Crossref
Shailima Rampogu & Keun Woo Lee. (2021) Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics. Frontiers in Chemistry 9.
Crossref
Serena Dotolo, Anna Marabotti, Angelo Facchiano & Roberto Tagliaferri. (2021) A review on drug repurposing applicable to COVID-19. Briefings in Bioinformatics 22:2, pages 726-741.
Crossref
Ilham M. Alshiraihi, Gerald L. Klein & Mark A. Brown. (2021) Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic. Diseases 9:1, pages 12.
Crossref
Camilla Isgrò, Anna Maria Sardanelli & Luigi Leonardo Palese. (2021) Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug. Viruses 13:1, pages 106.
Crossref
Tiana M. Scott, Sam Jensen & Brett E. Pickett. (2021) A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseases. F1000Research 10, pages 330.
Crossref
Tiana M. Scott, Sam Jensen & Brett E. Pickett. (2021) A signaling pathway-driven bioinformatics pipeline for predicting therapeutics against emerging infectious diseases. F1000Research 10, pages 330.
Crossref
Bianza Moise Bakadia, Feng He, Tiatou Souho, Lallepak Lamboni, Muhammad Wajid Ullah, Biaou Ode Boni, Abeer Ahmed Qaed Ahmed, Biampata Mutu Mukole & Guang Yang. (2021) Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. Biomedicine & Pharmacotherapy 133, pages 111008.
Crossref
Amutha Ramaswamy, Sangeetha Balasubramanian & Muthukumaran Rajagopalan. 2021. Molecular Docking for Computer-Aided Drug Design. Molecular Docking for Computer-Aided Drug Design 245 269 .
Mario Roberto Senger, Tereza Cristina Santos Evangelista, Rafael Ferreira Dantas, Marcos Vinicius da Silva Santana, Luiz Carlos Saramago Gonçalves, Lauro Ribeiro de Souza Neto, Sabrina Baptista Ferreira & Floriano Paes Silva-Junior. (2020) COVID-19: molecular targets, drug repurposing and new avenues for drug discovery. Memórias do Instituto Oswaldo Cruz 115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.